Maravai Lifesciences Holdings (MRVI) Research & Development (2020 - 2026)

Maravai Lifesciences Holdings' Research & Development history runs 7 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Research & Development fell 20.44% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $16.4 million (down 14.02% YoY), while the FY2025 annual figure was $17.4 million, down 9.46% from the prior year.
• Research & Development for Q1 2026 stood at $3.9 million, up from $3.8 million in the prior quarter.
• The five-year high for Research & Development was $5.4 million in Q3 2022, with the low at $3.7 million in Q1 2022.
• The 5-year median for Research & Development is $4.6 million (2024), against an average of $4.5 million.
• Peak annual rise in Research & Development reached 176.93% in 2022, while the deepest fall reached 45.44% in 2022.
• Maravai Lifesciences Holdings' Research & Development stood at $5.0 million in 2022, then slipped by 8.32% to $4.6 million in 2023, then declined by 0.72% to $4.6 million in 2024, then fell by 16.95% to $3.8 million in 2025, then climbed by 2.67% to $3.9 million in 2026.
• Business Quant data shows MRVI's Research & Development at $3.9 million in Q1 2026, $3.8 million in Q4 2025, and $3.8 million in Q3 2025.